NCT03101345View on ClinicalTrials.gov

High Energy Phosphate Metabolites in Brain

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

April 3, 2017

Primary Completion Date

July 7, 2017

Study Completion Date

July 21, 2017

Conditions
Healthy
Interventions
OTHER

Peptamen® 1.5 vanilla

Administration orally

Trial Locations (1)

1000

Metabolic Unit, Clinical Development Unit, Nestec, Lausanne

All Listed Sponsors
collaborator

Ecole Polytechnique Fédérale de Lausanne

OTHER

lead

Société des Produits Nestlé (SPN)

INDUSTRY

NCT03101345 - High Energy Phosphate Metabolites in Brain | Biotech Hunter | Biotech Hunter